Zevenbergen Capital Investments’s Gilead Sciences GILD Stock Holding History

Zevenbergen Capital Investments’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-327,645	Closed	-$27.3M	–	81
2016 Q2	$27.3M	Sell	327,645 -72,400	-18%	-$6.43M	1.28%	32
2016 Q1	$36.7M	Sell	400,045 -125,845	-24%	-$11.3M	1.66%	25
2015 Q4	$53.2M	Sell	525,890 -58,055	-10%	-$6.04M	2.16%	21
2015 Q3	$57.3M	Sell	583,945 -4,195	-0.7%	-$466K	2.46%	17
2015 Q2	$68.9M	Sell	588,140 -67,850	-10%	-$7.41M	2.68%	14
2015 Q1	$64.4M	Sell	655,990 -63,960	-9%	-$6.49M	2.69%	15
2014 Q4	$67.9M	Buy	719,950 +1,400	+0.2%	+$145K	2.94%	14
2014 Q3	$76.5M	Sell	718,550 -305,170	-30%	-$29.9M	3.27%	12
2014 Q2	$84.9M	Buy	1,023,720 +56,395	+6%	+$4.39M	2.98%	11
2014 Q1	$68.5M	Buy	967,325 +205,640	+27%	+$16.1M	2.45%	16
2013 Q4	$57.2M	Buy	+761,685	New	+$53M	1.97%	23

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zevenbergen Capital Investments's GILD Position: Q3 2016 in Review

Zevenbergen Capital Investments sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 327,645 shares — an estimated $27.3M sold.

Zevenbergen Capital Investments first reported a position in GILD in Q4 2013 and held it in 11 quarters. The position peaked at $84.9M in Q2 2014. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Zevenbergen Capital Investments reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Zevenbergen Capital Investments sold 327,645 Gilead Sciences shares in Q3 2016, an estimated $27.3M.
Zevenbergen Capital Investments first reported a position in Gilead Sciences in Q4 2013 and held it in 11 quarters.
Zevenbergen Capital Investments's Gilead Sciences position peaked at $84.9M in Q2 2014.
1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Zevenbergen Capital Investments's 13F filing for Q3 2016, filed 10 Nov 2016.